Why the study?
What are the strategies to minimize bleeding risk and its impact on mortality in patients undergoing percutaneous coronary intervention?
What are the strategies to minimize bleeding risk and its impact on mortality in patients undergoing percutaneous coronary intervention?
Bleeding during PCI is a major complication with profound effects on mortality, necessitating tailored strategies to minimize risk.
Bleeding minimization remains a PCI priority; leaves open which tailored strategies best reduce mortality.
The incidence of ischaemic complications during percutaneous intervention (PCI) has reduced over recent years. As a result, bleeding has now emerged as one of the most common complications of PCI in contemporary practice. In addition, measures intended to minimise ischaemic complications--such as balloon pumps or glycoprotein inhibitors--may actually increase bleeding frequency. Recent studies have not only highlighted the incidence with which major bleeding occurs but also demonstrated the profound effect of bleeding on mortality. Thus bleeding can no longer be considered an irritation that can simply be ignored or transfused. This review summarises the major trial and registry data obtained in a PubMed search combining the terms "bleeding" and "percutaneous coronary intervention" and then proposes strategies to minimise bleeding occurrence.
No takes yet. Share an insight, caveat, or question.
Kinnaird et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: